17 min read
Keypoint Newsletter: September 2025
Featuring...
Dr. Treviño’s research is focused on understanding the molecular basis by which exposure to endocrine disrupting chemicals disrupts the epigenetic machinery to promote the development of metabolic diseases with known disparities such as cancer, obesity and diabetes. Understanding the molecular mechanisms underlying epigenetic reprogramming may provide potential prevention strategies (for outreach and policy changes) and/or therapeutic targets for precision medicine approaches in high-risk populations.
Research Area(s):
Research Keywords:
Mentor: Ali Shilatifard, PhD
Sep 23, 2025 by Shannon Weiman
Featuring...
Sep 23, 2025 by Keystone Symposia
This month, we spotlight Keystone Symposia Fellow Dr. David R. Martinez, PhD, an assistant professor of immunobiology...